Back to ARWR

Vestal Point Capital, LP → ARWR

Vestal Point Capital, LP ARWR Position History

Arrowhead Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$315.1M
Q3 2026
Peak value
$315.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$59.8M
Q1 2026$142.6M
Q2 2026$128.4M
Q3 2026$315.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$315.1M4.82M——
Q2 2026$128.4M1.57M——
Q1 2026$142.6M2.27M——
Q4 2025$59.8M900.0K——

Other funds holding ARWR

Other Vestal Point Capital, LP positions

AAVXF

Abivax SA

$392.1M
NBIX

Neurocrine Biosciences Inc

$354.6M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
NBIX

Neurocrine Biosciences Inc

$316.8M
AAVXF

Abivax SA

$313.1M
INSM

Insmed Inc

$311M
UTHR

United Therapeutics Corp

$257.4M